ICU vs. BWAY, KRMD, BLUA, SRTS, HSAQ, ALUR, PDEX, NSPR, NVNO, and MGRM
Should you be buying SeaStar Medical stock or one of its competitors? The main competitors of SeaStar Medical include BrainsWay (BWAY), KORU Medical Systems (KRMD), BlueRiver Acquisition (BLUA), Sensus Healthcare (SRTS), Health Sciences Acquisitions Co. 2 (HSAQ), Allurion Technologies (ALUR), Pro-Dex (PDEX), InspireMD (NSPR), enVVeno Medical (NVNO), and Monogram Orthopaedics (MGRM). These companies are all part of the "surgical & medical instruments" industry.
BrainsWay (NASDAQ:BWAY) and SeaStar Medical (NASDAQ:ICU) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, community ranking, risk, valuation, analyst recommendations, media sentiment and institutional ownership.
BrainsWay received 61 more outperform votes than SeaStar Medical when rated by MarketBeat users. However, 100.00% of users gave SeaStar Medical an outperform vote while only 64.58% of users gave BrainsWay an outperform vote.
SeaStar Medical has a net margin of 0.00% compared to SeaStar Medical's net margin of -4.83%. BrainsWay's return on equity of 0.00% beat SeaStar Medical's return on equity.
BrainsWay has higher revenue and earnings than SeaStar Medical. BrainsWay is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.
30.1% of BrainsWay shares are held by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are held by institutional investors. 19.0% of BrainsWay shares are held by insiders. Comparatively, 3.0% of SeaStar Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
BrainsWay presently has a consensus price target of $13.00, indicating a potential upside of 106.68%. Given SeaStar Medical's higher possible upside, research analysts clearly believe BrainsWay is more favorable than SeaStar Medical.
In the previous week, BrainsWay had 2 more articles in the media than SeaStar Medical. MarketBeat recorded 4 mentions for BrainsWay and 2 mentions for SeaStar Medical. SeaStar Medical's average media sentiment score of 1.53 beat BrainsWay's score of 0.94 indicating that BrainsWay is being referred to more favorably in the media.
BrainsWay has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -0.96, meaning that its share price is 196% less volatile than the S&P 500.
Summary
BrainsWay beats SeaStar Medical on 12 of the 16 factors compared between the two stocks.
Get SeaStar Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ICU and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ICU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SeaStar Medical Competitors List
Related Companies and Tools
